We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.80
Bid: 0.00
Ask: 60.00
Change: 0.00 (0.00%)
Spread: 24.20 (67.598%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 35.80
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: HSBC announces redemption of US dollar securities

Thu, 15th Apr 2021 19:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

HSBC Holdings PLC - London-based bank - Announces the redemption of its USD2.00 billion 6.875% perpetual subordinated contingent convertible securities. The redemption price will be USD1,000 per USD1,000 of the securities together with any accrued but unpaid interest.

----------

RHI Magnesita NV - Vienna, Austria-headquartered supplier of refractory products - Notes appointment of Non-Executive Director Janet Ashdown as an independent non-executive director of Stolt-Nielsen Ltd, listed on the Oslo Bors.

----------

Blue Star Capital PLC - investment company with a focus on esports, payments, technology and its applications within media and gaming - Says investee Dynasty eSports Pte Ltd achieved its first monthly profit on an operating basis in January. Says Dynasty expects to shortly conclude a round of fundraising in which it is targeting to raise approximately USD5 million. Blue Star retains anti-dilution rights and is considering exercising these rights to participate in Dynasty's fundraising round. Blue Star currently holds approximately 13% of Dynasty.

----------

Alliance Pharma PLC - pharmaceutical company based in Wiltshire - Says Non-Executive Director Nigel Clifford to step down on April 30 after serving for six years.

----------

Futura Medical PLC - Surrey-based pharmaceutical company - Receives conversion notice from HT Riverwood Multi-Growth Fund, managed by Atlantis Investment Management Ltd, for GBP1.5 million loan notes. Says following this there will be no further amounts outstanding to Riverwood. Says following the conversion, Futura will issue 7.5 million shares at a conversion price of 20 pence per share.

----------

CEPS PLC - Bath, England-based investment company focussed on the industrial sector - Says subsidiary Hickton Group Ltd enters a four-year GBP500,000 Coronavirus Business Interruption Loan with Santander UK PLC. Proceeds will be used for general corporate purposes. Says the loan is repayable in 11 consecutive equal quarterly payments starting approximately 12 months after drawdown.

----------

Tavistock Investments PLC - Berkshire-based investment manager - Says holders of 42% of its shares are against possible Team PLC offer. On Wednesday, Tavistock received letters of intent from holders of 25% of shares saying they will reject the possible all-share offer by Team. In addition, Tavistock board members, who own a 16% stake, would not accept an offer at that level from Team as it significantly undervalues the business. On March 23, Jersey-based investment manager Team announced a possible all-share offer for Tavistock worth GBP15.2 million, or 2.5 pence per share. Tavistock's market capitalisation is GBP15.8 million.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Withdraws application for maintenance of Europe Efmody orphan designation. Says this follows feedback from the Committee for Orphan Medicinal Products, an advisory committee to the European Medicines Agency. "Diurnal has decided that continuing pursuit of an Orphan Designation for the drug would be likely to cause a significant delay in its European commercial launch. First commercial launch is currently anticipated to be in Q3 2021," says Diurnal.

----------

Emmerson PLC - Khemisset potash project in northern Morocco - Completes phased development plan for Khemisset potash project. Expects "significantly reduced up-front capex" of USD254.6 million. Expects earnings before interest, tax, depreciation and amortisation in first full year of phase four production of USD491.4 million.

----------

CATCo Reinsurance Opportunities Fund Ltd - investor focused on offering returns from investments linked to catastrophe reinsurance risks - Advised of further side pocket investment release amounting to USD19.2 million. Says it is expected to be paid to the company in May, following which the company intends to use it to carry out a seventh compulsory redemption of its shares.

----------

Caerus Mineral Resources PLC - exploration & resource development company focused on minerals in Europe to supply global clean energy drive - Says drilling in Cyprus has begun ahead of schedule. Says Mines Department of Cyprus has accepted its applications for the Kapedes and Vrechia extension licences. Says formal granting of licences expected to take several months but will commence reconnaissance geological mapping and sampling in the interim.

----------

Valeura Energy Inc - Canada-based company engaged in the exploration, development and production of petroleum and natural gas in Turkey - Agrees with TBNG Ltd to amend long stop date for completion of the sale of its shallow conventional gas business for USD15.5 million. Valeura will be entitled to royalty payments over a five-year period, with a minimum royalty payment of USD1.0 million, and maximum of USD2.5 million.

----------

Chesterfield Resources PLC - copper explorer focused on Cyprus - Announces that it has commenced its 2021 mineral exploration campaign in Cyprus. The company is exploring for further copper, gold, zinc and silver, after its successful diamond drill programme of late 2020. Says 15 percussion drill holes are planned during April and May.

----------

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
10 Apr 2024 10:49

Futura Medical hails results as erectile dysfunction drug drives sales

(Alliance News) - Futura Medical PLC on Wednesday celebrated its "first set out meaningful revenues" in 2023, as sales for its erectile dysfunction treatment climbed.

Read more
3 Apr 2024 12:58

UK earnings, trading statements calendar - next 7 days

Thursday 4 April 
LungLife AI IncFull Year Results
Friday 5 April 
no events scheduled 
Monday 8 April 
Bango PLCFull Year Results
Ferrexpo PLCTrading Statement
Globaltrans Investment PLCFull Year Results
Tuesday 9 April 
Alliance Pharma PLCFull Year Results
CMC Markets PLCTrading Statement
hVIVO PLCFull Year Results
Imperial Brands PLCTrading Statement
JTC PLCFull Year Results
S&U PLCFull Year Results
Ultimate Products PLCHalf Year Results
Wednesday 10 April 
Churchill China PLCFull Year Results
Futura Medical PLCFull Year Results
M&C Saatchi PLCFull Year Results
Marshalls PLCFull Year Results
Tesco PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
14 Feb 2024 09:24

IN BRIEF: Futura Medical's Eroxon to soon be available on prescription

Futura Medical PLC - Guildford, England-based pharmaceutical company focused on sexual health products - Confirms that lead product Eroxon will from March 1 be available on prescription in England and Wales for the treatment of erectile dysfunction. Eroxon is a gel-based treatment designed to help the user obtain an erection, and serves as an alternative for people who are unwilling or unable to use medications like Viagra. Eroxon has also been available without a prescription in UK pharmacies since March last year.

Read more
6 Feb 2024 17:04

LONDON MARKET CLOSE: BP and Prudential help snap FTSE losing streak

(Alliance News) - Stock prices in London pushed higher on Tuesday, with the FTSE 100 registering its first rise in four trading days, with oil major BP the star performer.

Read more
6 Feb 2024 12:24

Futura Medical shares surge after "transformational year"

(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon.

Read more
6 Feb 2024 10:08

Futura has 'transformational year' in 2023

(Sharecast News) - Consumer healthcare company Futura said on Tuesday that 2023 had been a "transformational year", with the group generating its first meaningful revenues and laying the foundations for "significant growth acceleration".

Read more
15 Jan 2024 14:59

Futura Medical extends agreement with Cooper Consumer Health

(Sharecast News) - Sexual health product developer Futura Medical announced an extension of its exclusive licensing agreement with Cooper Consumer Health on Monday.

Read more
15 Jan 2024 08:35

Futura Medical extends licensing deal for erectile dysfunction gel

(Alliance News) - Futura Medical PLC on Monday said that it has extended its exclusive licensing agreement with Cooper Consumer Health Group, a European self-care organisation, to January 2029.

Read more
7 Nov 2023 17:47

TRADING: Zambeef sees profit above market views; Luceco trades in line

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
25 Oct 2023 12:21

Futura Medical gets Mexico marketing authorisation for Eroxon gel

(Alliance News) - Futura Medical PLC on Wednesday said the Mexican Secretariat of Health has granted over the counter sale marketing authorisation for its erectile dysfunction topical gel formulation Eroxon.

Read more
19 Oct 2023 14:17

IN BRIEF: Futura Medical launches erectile dysfunction gel in UAE

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says that it has launched Exoron in the United Arab Emirates. Exoron, or MED3000, is a topical gel used to treat erectile dysfunction. It uses Futura's proprietary technology, DermaSys. The product is now available for purchase online through the BinSina Pharmacy in the UAE, the first market in the Middle East to stock the product.

Read more
2 Oct 2023 14:22

Futura Medical wis European patent for erectile dysfunction gel

(Sharecast News) - Sexual health specialist Futura Medical announced the successful acquisition of an EU patent for its MED3000 topical erectile dysfunction product on Monday.

Read more
2 Oct 2023 12:13

IN BRIEF: Futura Medical granted European patent for ED treatment

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Receives European patent for erectile dysfunction treatment, MED3000, until 2040. Continues to pursue patent applications to provide wider patent protection. Chief Executive Officer James Barder says: "The allowance of this patent application further cements the intellectual property of MED3000, as we support our distributors' roll out of our fast acting topically applied gel for the treatment of erectile dysfunction available without a doctor's prescription across the world."

Read more
18 Sep 2023 11:28

TRADING UPDATES: Elixirr record half-year revenue; Bango profit down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Sep 2023 15:44

UK earnings, trading statements calendar - next 7 days

Tuesday 12 September 
Associated British Foods PLCTrading Statement
Cornerstone FS PLCHalf Year Results
Creo Medical Group PLCHalf Year Results
Digital 9 Infrastructure PLCHalf Year Results
Dowlais Group PLCHalf Year Results
Eleco PLCHalf Year Results
Equals Group PLCHalf Year Results
Feedback PLCFull Year Results
Fevertree Drinks PLCHalf Year Results
Gym Group PLCHalf Year Results
Harworth Group PLCHalf Year Results
hVIVO PLCHalf Year Results
IQE PLCHalf Year Results
Itaconix PLCHalf Year Results
JTC PLCHalf Year Results
Keywords Studios PLCHalf Year Results
Mattioli Woods PLCFull Year Results
Ocean Harvest Technology Group PLCHalf Year Results
Property Franchise Group PLCHalf Year Results
Regional REIT LtdHalf Year Results
Smart Metering Systems PLCHalf Year Results
Wednesday 13 September 
abrdn Smaller Companies Income Trust PLCHalf Year Results
Argentex Group PLCHalf Year Results
Brave Bison Group PLCHalf Year Results
Burford Capital LtdHalf Year Results
CAB Payments Holdings PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Frontier Developments PLCFull Year Results
Made Tech Group PLCFull Year Results
On The Beach Group PLCTrading Statement
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Ricardo PLCFull Year Results
Star Energy Group PLCHalf Year Results
Tullow Oil PLCHalf Year Results
Thursday 14 September 
Arecor Therapeutics PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Capricorn Energy PLCHalf Year Results
Checkit PLCHalf Year Results
Churchill China PLCHalf Year Results
Foresight Solar Fund LtdHalf Year Results
Glenveagh Properties PLCHalf Year Results
IG Group Holdings PLCTrading Statement
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
M&C Saatchi PLCHalf Year Results
MJ Gleeson PLCFull Year Results
Oakley Capital Investments LtdHalf Year Results
Renishaw PLCFull Year Results
Spire Healthcare Group PLCHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Uniphar PLCHalf Year Results
Friday 15 September 
Petra Diamonds LtdFull Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Monday 18 September 
Artisanal Spirits Co PLCHalf Year Results
City of London Investment Group PLCFull Year Results
Downing Renewables & Infrastructure Trust PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Futura Medical PLCHalf Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Phoenix Group Holdings PLCHalf Year Results
S4 Capital PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.